Indegene Launches Hyderabad Center to Enhance Life Sciences Innovation
Digital-first life sciences commercialization company Indegene announced a new center in Hyderabad to strengthen its global delivery operations and better address growing business needs.
The new center will play a critical role in helping companies accelerate their transformation with the huge pressure that has been put on the pharma industry to innovate and adapt. This too, again aligns with the purpose of Indegene: enabling healthcare organizations to be future-ready by combining deep medical expertise with fit-for-purpose technology.
India is quickly emerging as a high value hub for international pharma companies, lured by its large pool of highly skilled medical and technology talent. The pharma companies are looking increasingly for a core domain-experienced partner who could enable them to scale in a non-linear, technology-led manner.
Indegene has a proven track record of helping international pharma companies reimagine their commercialization processes, drive innovation with GenAI, and fully integrate these capabilities into business operations", comments Manish Gupta, Chairman and CEO of Indegene. "With this new center, we're further building on our capabilities to enable life sciences companies to modernize and transform their commercial, medical, and clinical operations, with our fit-for-purpose technology".
Everest Group recognized Indegene's leadership in commercialization in life sciences by leveraging it as a Leader in its Life Sciences Digital Services Specialist PEAK Matrix Assessment 2024. HFS Research recently named Indegene a Leader in GenAI in Life Sciences, further validating the latter's focus on innovation and excellence in the industry.
The client base consists of the world's top 20 biopharma companies, many emerging biotech firms, and medical device companies. Spanning 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene's great global footprint is a testament to how the company has been able to scale up to the needs of the world's leading pharma organizations across markets.
